Recently, we demonstrated that these NRs inhibit the growth of triple negative, estrogen receptor alpha (ER-α) and Her2-overexpressing breast cancer cells by blocking MNK initiated eIF4E activation [19]. Here, ERBB2 is linked to breast carcinoma.